Introduction

humans.
2 Gene transfer to normal lymphocytes using Successful introduction of foreign genes into normal MuLV is thus accomplished ex vivo, with mitogenic human peripheral blood mononuclear cells (PBMC) has stimulation to render these cells susceptible to MuLV been an elusive goal. This cell population, consisting infection. This approach has been used in attempts to mostly of lymphocytes and monocytes, is an important treat such hereditary diseases as Gaucher's disease and target for gene transfer therapy, for both hereditary disadenosine deaminase deficiency. 3, 4 eases, such as chronic granulomatous disease, and for Because of generally low transduction efficiency, mulacquired diseases, such as AIDS. These cells may also be tiple exposures to MuLV are used, often followed by targets of therapeutic manipulation for other purposes, selection procedures to enrich the study population by eg to control transplant rejection or to kill tumor cells.
eliminating cells that are not effectively transduced.
5
However they have proven to be difficult targets for curRelatively small numbers of transduced cells can be prorently used gene transfer vectors.
duced for reimplantation using such procedures. Other Most applications of gene transfer to PBMC necessitate complications of MuLV-based gene transfer have also long-term expression of the transferred gene, and so been noted. treated ex vivo then reinfused into syngeneic hosts.
9
The ability to transfer gene expression to nondividing cells of hematopoietic origin may enable successful gene transfer in vivo on a scale that could be therapeutically significant, particularly if transduction efficiencies were high enough to administer the vector directly to the targeted cells in the patient and so avoid the need for ex vivo selection. SV40 can transfer gene expression to resting murine cells in vivo (eg neurons). 9 We therefore asked whether SV40-derived vectors might be candidate vehicles for direct gene transfer to human PBMC by testing SV40 transduction of normal, resting human peripheral blood cells. For these studies, we used two different reporter gene constructs, one containing hepatitis B surface antigen (HBSAg) and one containing firefly luciferase (luc). We report here the successful application of SV40 to short-term transduction of PBMC.
Results
Detection of luciferase and HBSAg transcripts in PBMC transduced with SVluc and SV(HBS)
The plasmid constructs used to generate recombinant SV40 viruses are illustrated in Figure 1 , and described in the Materials and methods. The use of such constructs to Figure 1 (c make recombinant, replication-deficient SV40 is Detection of HBSAg and luciferase in PBMC following infection in vitro described elsewhere.
Figure 1 (b) Schematic map of pSV5. This plasmid was constructed from pBSV(⌬T′) by inserting a modified pGEM5 multiple cloning site (mcs) into the limited pre-existing mcs, then excising the viral genome from pBR322, and cloning it into pGEM13 using the NotI site in the new mcs.
Figure 1 Maps of pBSV(luc), pSV5 and pSV5(HBS). (a) Schematic map of pBSV(luc). The cloning procedure used to generate this plasmid has been described in detail elsewhere, and is related briefly in the Materials and methods. The virus genome is cloned into pBR322 as a BamHI fragment. This construct contains two head-to-tail SV40 EP, followed by the
9,10 Briefly, pBSV(luc) was derived from pBSV-1 (kind gift of Dr JS Butel, Baylor College of To determine whether detectable levels of the respective proteins were produced following transduction in culMedicine), in which the SV40 genome was cloned into pBR322. We modified this plasmid by excising the Tag ture, PBMC were infected as described, at an MOI of 0.5, and cultured without stimulation for 24 h. Cells were gene, and adding the luciferase gene. pBSV(luc) was used to produce a recombinant SV40-derivative virus, SVluc. then cytocentrifuged and prepared for immunostaining as in the Materials and methods. Protein production was To make an SV40-derived virus that would express hepatitis B surface antigen (HBSAg), a different Tag-, SV40-visualized by immunostaining. SV(HBS)-and SVlucinfected PBMC expressed their respective proteins, as containing plasmid construct was used, pSV5. The HBSAg gene cloned into pSV5 yielded pSV5(HBS), as detected by anti-HBSAg and anti-luc antibodies in immunostains (Figure 3) . The same cells, treated with normal illustrated. We used pSV5(HBS) to make an SV40 derivative virus, SV(HBS), in which the HBSAg gene was Ig instead of anti-HBSAg or anti-luc antibody, were negative by this assay. As a further control for the specificity cloned downstream from two tandem SV40 early promoters.
of this staining reaction, mock-infected PBMC stained using anti-HBSAg or anti-luc antibody were negative as PBMC were transduced with either SVluc or SV(HBS) at an MOI of 10. Control cells were mock-infected. Total well (Figure 3 ). RNA from each treatment group was extracted 24 h after transduction, electrophoresed on the same gel, transExpression of luciferase in PBMC stimulated with con A To determine whether reporter gene expression was ferred to the same filter and hybridized simultaneously with cDNA probes for the two reporter genes tested. In greater in stimulated, as opposed to resting, PBMC, cultures of PBMC were treated with con A (2 g/ml) simulthis fashion, cells from each virus treatment group served as additional controls for PBMC infected with the other taneously with exposure to SVluc or SV(HBS) (MOI, 10). Cells were harvested 2 days later. Total RNA was virus. That is, for example RNA from SVluc-infected cells, as well as RNA from mock-infected cells, were conextracted, electrophoresed, blotted and hybridized simultaneously with luciferase cDNA and HBSAg DNA. As trols for identifying expression of HBSAg from SV(HBS)-transduced cells. SV40-derived vectors transduced controls, these blots were hybridized with cDNA for GAPDH. After correction for control (GAPDH) mRNA expression of luciferase and HBSAg in resting PBMC (Figure 2 ). Mock-infected cells did not express either gene levels, luc expression appeared slightly greater in PBMC stimulated with con A than in resting PBMC (Ͻ25% difdetectably. Cells from each transduced experimental group expressed only the transgene with which they had ference, Figure 4) . Oddly, levels of HBSAg transcript, which were clearly detectable in unstimulated cells, were been transduced. not detected in stimulated PBMC. Mock-infected cells expressed neither HBSAg nor luciferase.
Infectivity of PBMC with SVluc and SV(HBS) as a function of con A stimulation
We next tested whether con A simulation altered the ability of either SVluc to infect PBMC. Con A-stimulated (2 g/ml) PBMC cultures were exposed to SVluc at an MOI of 0.5. The percentage of virus-infected cells was determined after cell harvest, 24 h later. In control (unstimulated) cultures, 30 ± 5% (s.d.) of cells were infected with virus, while in con A-stimulated cultures, 34 ± 7% of cells were infected with virus. Thus, the infectivity of SVluc was not altered by stimulating targeted cells.
Discussion
Transduction of bone marrow-derived cell populations was an early clinical application of gene transfer technology. 3 While the field of gene transfer has burgeoned recently, bone marrow-derived cells are among the most enticing of targets for gene delivery: autologous cells may be recovered relatively easily, manipulated ex vivo and cultured and selected for substantial periods of time 
SV40 derivative viruses containing these reporter genes. SVluc and SV(HBS) were used to transduce normal, resting, human PBMC in vitro
Of the expanding pool of available viral gene transfer at an MOI of 10. Mock-infected cells were treated similarly but were agents, MuLV has been used most extensively to transexposed to control preparations, rather than infectious virus. RNA was duce PBMC. 12 The strengths and weaknesses of this vec- minichromosomes (which produce Tag) may replicate and be carried to daughter cells. Tag-deficient SV40 epi-SV40 is a small (5.2 kb) nonenveloped double-stranded DNA virus of the papilloma virus family. It infects and somes may not. SV40 encodes five genes, including three structural genes and large and small T antigens. 20 Large expresses its genes in cells of many tissues of origin, and of many different animal species. Live, wild-type (wt) T antigen (Tag) is both the transforming protein of SV40 and the principal antigenic target recognized by the SV40 was an unrecognized contaminant in early lots of polio vaccines, and was inadvertently administered to immune system at the plasma membranes of infected cells. [21] [22] [23] Tag expression is required for virus replication many polio vaccine recipients. SV40 sequences and SV40-like sequences have been detected in some human and for expression of the late genes. Tag-deficient SV40 can be grown easily and to relatively high titer (10 9 to tumors, often in cases with no known exposure to the virus. 16, 17 Extensive epidemiologic studies on polio vac-10 10 infectious virus per milliliter) in COS cells without
